aTyr Pharma
ATYR
#9471
Rank
NZ$0.13 B
Marketcap
NZ$1.41
Share price
0.95%
Change (1 day)
-75.22%
Change (1 year)

Revenue for aTyr Pharma (ATYR)

Revenue in 2025 (TTM): NZ$0.32 Million

According to aTyr Pharma's latest financial reports the company's current revenue (TTM ) is NZ$0.32 Million. In 2024 the company made a revenue of NZ$0.41 Million a decrease over the revenue in the year 2023 that were of NZ$0.55 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for aTyr Pharma from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0.32 M-21.33%
2024 NZ$0.41 M-25.35%
2023 NZ$0.55 M-96.59%
2022 NZ$16.35 M
2021 N/A-100%
2020 NZ$14.48 M2212.46%
2019 NZ$0.62 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Veracyte
VCYT
NZ$0.85 B 260,500.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$20.18 B 6,170,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA